The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.

Rein DB, Wittenborn JS, Smith BD, et al. The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus. Clin Infect Dis. 2015;61(2):157-168.

Publication Type:

Journal Article

Authors:

Rein, DB.; Wittenborn, JS.; B.D. Smith; et, al

Source:

Clin Infect Dis., Volume 61, Issue 2, p.157-168 (2015)

Cited On:

Export Citation:
RIS Format
Top